Vascon Engineers Limited has officially received a Letter of Intent from Reliance Industries Limited for a construction project valued at Rs. 131.58 Crore, excluding GST. The project involves the construction of four G+12 FLL type buildings for Sector-3 at the RG Expansion project in Jamnagar. This contract is to be executed on a Bill of Quantities (BOQ) basis and is scheduled for completion within 19 months from the date of receiving the order.

This major contract marks a significant development for Vascon Engineers Limited, as it enhances the company’s presence in the high-stakes industrial construction segment. By securing a project from a prominent conglomerate like Reliance Industries, the company reinforces its capability to manage large-scale industrial civil works, which is expected to bolster its order book and revenue visibility for the upcoming fiscal periods.

Founded in 1986 and headquartered in Pune, Vascon Engineers Limited is a multifaceted construction and real estate company. The company operates primarily through Engineering, Procurement, and Construction (EPC) services and Real Estate (RE) Development, with a focus on critical infrastructure such as hospitals, IT parks, and residential complexes. Throughout 2025, the company continued to leverage its asset-light strategy in real estate while targeting high-value government civil contracts in its EPC division. Recent strategic efforts have included a focus on debt reduction and expansion into redevelopment projects in Mumbai.

For the financial results pertaining to the quarter ended March 31, 2026, the company reported a consolidated net profit of Rs. 5.72 Crore, marking a significant decline of approximately 83.55% compared to the Rs. 34.77 Crore reported in the same quarter of the previous year. Revenue from operations for the quarter stood at Rs. 258.93 Crore, representing a decrease of approximately 34.08% year-on-year. Regarding shareholding, while there are no prominent institutional investors like mutual funds holding shares, the company counts individuals such as Dr. Santosh Sundararajan among its significant public shareholders.